|
127 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3245 News |
|
| «12...3435363738394041424344...6566» |
- |||| Nimenrix (MenACWY-TT) / Pfizer
Trial primary completion date: Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects (clinicaltrials.gov) - Jun 4, 2014
P3, N=100, Recruiting, Sponsor: GlaxoSmithKline
Trial primary completion date: Feb 2014 --> Nov 2014
- Clinical: MaTuTU: Establishment of a Clinical Trial Unit in Mavalane, Maputo, in Mozambique (clinicaltrials.gov) - Jun 3, 2014
P=N/A, N=80, Not yet recruiting, Sponsor: Michael Hoelscher
- | lignocaine / Generic mfg.
Trial initiation date: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (clinicaltrials.gov) - Jun 2, 2014
P2/3, N=500, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Trial primary completion date: Feb 2014 --> Nov 2014 Initiation date: Oct 2013 --> May 2014
- | lignocaine / Generic mfg.
Enrollment open: A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (clinicaltrials.gov) - Jun 2, 2014
P2/3, N=500, Recruiting, Sponsor: Postgraduate Institute of Medical Education and Research
Initiation date: Oct 2013 --> May 2014 Not yet recruiting --> Recruiting
- Clinical: Iron Homoeostasis in Inflammation (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=1500, Recruiting, Sponsor: University Hospital, Basel, Switzerland
- vancomycin / Generic mfg.
Trial primary completion date: Prospective Evaluation of a Vancomycin Nomogram With a Continuous Infusion of Vancomycin for Surgical ICU Patients (clinicaltrials.gov) - Jun 1, 2014
P4, N=120, Recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Trial primary completion date: Apr 2014 --> Jul 2015
- Trial primary completion date, Endobronchial ultrasound, Biopsy: EBUS-TBNA Versus EBUS-TBNB (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=250, Recruiting, Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Trial primary completion date: Apr 2014 --> Jul 2015 Trial primary completion date: Sep 2013 --> Jun 2016
- Trial initiation date, Endobronchial ultrasound, Biopsy: EBUS-TBNA Versus EBUS-TBNB (clinicaltrials.gov) - Jun 1, 2014
P=N/A, N=250, Recruiting, Sponsor: Royal Brompton & Harefield NHS Foundation Trust
Trial primary completion date: Sep 2013 --> Jun 2016 Initiation date: Oct 2011 --> May 2014
- |||| moxifloxacin ophthalmic / Generic mfg., ofloxacin ophthalmic / Generic mfg.
Trial primary completion date: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients (clinicaltrials.gov) - May 29, 2014
P3, N=955, Completed, Sponsor: Alcon Research
Initiation date: Oct 2011 --> May 2014 Trial primary completion date: Jul 2014 --> Apr 2014
- ||||||| moxifloxacin ophthalmic / Generic mfg., ofloxacin ophthalmic / Generic mfg.
Trial completion: An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients (clinicaltrials.gov) - May 29, 2014
P3, N=955, Completed, Sponsor: Alcon Research
Trial primary completion date: Jul 2014 --> Apr 2014 Recruiting --> Completed
- |||||| Enrollment open: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. (clinicaltrials.gov) - May 29, 2014
P3, N=150, Recruiting, Sponsor: Novartis
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||||| Boostrix (tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine) / GSK
Trial completion: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children (clinicaltrials.gov) - May 28, 2014
P3, N=302, Completed, Sponsor: GlaxoSmithKline
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Pneumovax 23 (23-valent pneumococcal polysaccharide) / Merck (MSD), PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Enrollment open: Systems Biology of PNEUMOVAX®23 and PREVNAR 13® (clinicaltrials.gov) - May 28, 2014
P=N/A, N=88, Recruiting, Sponsor: Emory University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: RVMM Study: Study of the Microbiota, Metabolome, and Environmental Toxins in Relation to Reproductive Health in Rwandan Women (clinicaltrials.gov) - May 28, 2014
P0, N=30, Completed, Sponsor: Western University, Canada
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- ||| Trial completion date: Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India (clinicaltrials.gov) - May 27, 2014
P3, N=180, Completed, Sponsor: Novartis
Not yet recruiting --> Completed Trial completion date: Jul 2014 --> Apr 2014
- azithromycin / Generic mfg.
Trial primary completion date: PregnAnZI: Prevention of Bacterial Infections in Newborn (clinicaltrials.gov) - May 26, 2014
P3, N=830, Recruiting, Sponsor: Medical Research Council Unit, The Gambia
Trial completion date: Jul 2014 --> Apr 2014 Trial primary completion date: Mar 2014 --> Jun 2014
- Gammaplex (intravenous normal human immunoglobulin) / Bio Products Lab
Trial completion: A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency (clinicaltrials.gov) - May 26, 2014
P4, N=25, Completed, Sponsor: Bio Products Laboratory
Trial primary completion date: Mar 2014 --> Jun 2014 Active, not recruiting --> Completed
- Enrollment change, Surgery: Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery (clinicaltrials.gov) - May 26, 2014
P2, N=33, Completed, Sponsor: Yuejiang Liu
Active, not recruiting --> Completed N=60 --> 33
- Trial completion, Surgery: Validity Study of Glutamine to Improve Cardiac Function in Cardiac Surgery (clinicaltrials.gov) - May 26, 2014
P2, N=33, Completed, Sponsor: Yuejiang Liu
N=60 --> 33 Recruiting --> Completed
- Trial completion date: Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. (clinicaltrials.gov) - May 25, 2014
P4, N=122, Completed, Sponsor: University of Zurich
Recruiting --> Completed Trial completion date: Dec 2013 --> May 2014
- Enrollment change: Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. (clinicaltrials.gov) - May 25, 2014
P4, N=122, Completed, Sponsor: University of Zurich
Trial completion date: Dec 2013 --> May 2014 N=300 --> 122
- Enrollment change: A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (clinicaltrials.gov) - May 25, 2014
P1/2, N=0, Withdrawn, Sponsor: AM-Pharma
N=300 --> 122 N=20 --> 0
- Trial completion: Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia. (clinicaltrials.gov) - May 25, 2014
P4, N=122, Completed, Sponsor: University of Zurich
N=20 --> 0 Not yet recruiting --> Completed
- | Enrollment closed: Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC (clinicaltrials.gov) - May 25, 2014
P3, N=500, Active, not recruiting, Sponsor: Institute of Tropical Medicine, Belgium
Not yet recruiting --> Completed Recruiting --> Active, not recruiting
- Trial primary completion date: Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg (clinicaltrials.gov) - May 22, 2014
P=N/A, N=80, Recruiting, Sponsor: Charite University, Berlin, Germany
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2014 --> Oct 2014
- Trial completion date: Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg (clinicaltrials.gov) - May 22, 2014
P=N/A, N=80, Recruiting, Sponsor: Charite University, Berlin, Germany
Trial primary completion date: Feb 2014 --> Oct 2014 Trial completion date: Feb 2014 --> Oct 2014
- || Trial primary completion date: OPTIMIST: QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (clinicaltrials.gov) - May 21, 2014
P4, N=870, Active, not recruiting, Sponsor: Hospital Universitari de Bellvitge
Trial completion date: Feb 2014 --> Oct 2014 Trial primary completion date: Jul 2013 --> Feb 2016
- || Trial completion date: OPTIMIST: QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (clinicaltrials.gov) - May 21, 2014
P4, N=870, Active, not recruiting, Sponsor: Hospital Universitari de Bellvitge
Trial primary completion date: Jul 2013 --> Feb 2016 Trial completion date: Jul 2013 --> Feb 2016
- ||| Enrollment closed: OPTIMIST: QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. (clinicaltrials.gov) - May 21, 2014
P4, N=870, Active, not recruiting, Sponsor: Hospital Universitari de Bellvitge
Trial completion date: Jul 2013 --> Feb 2016 Recruiting --> Active, not recruiting
- Trial primary completion date: Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock (clinicaltrials.gov) - May 21, 2014
P=N/A, N=361, Recruiting, Sponsor: University of British Columbia
Recruiting --> Active, not recruiting Trial primary completion date: Sep 2013 --> Dec 2014
- Trial completion date: Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock (clinicaltrials.gov) - May 21, 2014
P=N/A, N=361, Recruiting, Sponsor: University of British Columbia
Trial primary completion date: Sep 2013 --> Dec 2014 Trial completion date: Dec 2013 --> Feb 2015
- Enrollment open: Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock (clinicaltrials.gov) - May 21, 2014
P=N/A, N=361, Recruiting, Sponsor: University of British Columbia
Trial completion date: Dec 2013 --> Feb 2015 Not yet recruiting --> Recruiting
- |||| TOBI Podhaler (tobramycin inhalation powder) / Viatris
Trial completion: Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis (clinicaltrials.gov) - May 21, 2014
P4, N=157, Completed, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- New P1 trial: Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. (clinicaltrials.gov) - May 21, 2014
P1, N=6, Not yet recruiting, Sponsor: Verisfield UK Ltd. Greek Branch
- Altabax (retapamulin) / GSK, Almirall
Enrollment closed: Retapamulin Microdialysis Feasibility Study (clinicaltrials.gov) - May 21, 2014
P1, N=3, Active, not recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Onbrez (indacaterol) / Novartis
Trial primary completion date: INFINITY: Indacaterol EfectIveness In COPD Patients With Tuberculosis History (clinicaltrials.gov) - May 20, 2014
P3, N=132, Recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2014 --> Aug 2014
- albendazole / Generic mfg., azithromycin / Generic mfg.
Trial withdrawal: AZIVAL2: Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (clinicaltrials.gov) - May 20, 2014
P4, N=0, Withdrawn, Sponsor: Emory University
Trial primary completion date: Feb 2014 --> Aug 2014 Not yet recruiting --> Withdrawn
- ||| Onbrez (indacaterol) / Novartis
Trial completion date: INFINITY: Indacaterol EfectIveness In COPD Patients With Tuberculosis History (clinicaltrials.gov) - May 20, 2014
P3, N=132, Recruiting, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Withdrawn Trial completion date: Feb 2014 --> Aug 2014
- albendazole / Generic mfg., azithromycin / Generic mfg.
Enrollment change: AZIVAL2: Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis (clinicaltrials.gov) - May 20, 2014
P4, N=0, Withdrawn, Sponsor: Emory University
Trial completion date: Feb 2014 --> Aug 2014 N=3680 --> 0
- Clinical: Simplified GBS Screening and Prevalence of ESBL in Pregnant Women (clinicaltrials.gov) - May 18, 2014
P=N/A, N=480, Not yet recruiting, Sponsor: University Hospital, Basel, Switzerland
- ethambutol / Generic mfg.
Trial primary completion date: Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography (clinicaltrials.gov) - May 18, 2014
P=N/A, N=49, Completed, Sponsor: Yonsei University
N=3680 --> 0 Trial primary completion date: Feb 2014 --> May 2014
- ethambutol / Generic mfg.
Trial completion date: Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography (clinicaltrials.gov) - May 18, 2014
P=N/A, N=49, Completed, Sponsor: Yonsei University
Trial primary completion date: Feb 2014 --> May 2014 Trial completion date: Feb 2014 --> May 2014
- ethambutol / Generic mfg.
Enrollment change: Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography (clinicaltrials.gov) - May 18, 2014
P=N/A, N=49, Completed, Sponsor: Yonsei University
Trial completion date: Feb 2014 --> May 2014 N=100 --> 49
- ethambutol / Generic mfg.
Trial completion: Early Retinal Nerve Fiber Layer Change of Ethambutol Optic Neuropathy by Optical Coherence Tomography (clinicaltrials.gov) - May 18, 2014
P=N/A, N=49, Completed, Sponsor: Yonsei University
N=100 --> 49 Not yet recruiting --> Completed
- | New P4 trial: Bacteraemia Secondary to Tooth Extraction: Chlorhexidine Prophylaxis Protocols (clinicaltrials.gov) - May 15, 2014
P4, N=208, Completed, Sponsor: University of Santiago de Compostela
- ||||| clindamycin phosphate / Generic mfg., amoxycillin/clavulanate / Generic mfg.
New P4 trial: AUGDENT: AUGMENTIN™ in Dental Infections (clinicaltrials.gov) - May 15, 2014
P4, N=472, Completed, Sponsor: GlaxoSmithKline
- || Trial primary completion date: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (clinicaltrials.gov) - May 15, 2014
P2, N=500, Active, not recruiting, Sponsor: JN-International Medical Corporation
Not yet recruiting --> Completed Trial primary completion date: Oct 2014 --> May 2014
- || Trial completion date: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (clinicaltrials.gov) - May 15, 2014
P2, N=500, Active, not recruiting, Sponsor: JN-International Medical Corporation
Trial primary completion date: Oct 2014 --> May 2014 Trial completion date: Oct 2014 --> Nov 2014
- ||| Enrollment closed: Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (clinicaltrials.gov) - May 15, 2014
P2, N=500, Active, not recruiting, Sponsor: JN-International Medical Corporation
Trial completion date: Oct 2014 --> Nov 2014 Recruiting --> Active, not recruiting
- |||||||||| New P3 trial: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. (clinicaltrials.gov) - May 15, 2014
P3, N=150, Not yet recruiting, Sponsor: Novartis